跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 1,123 条关于
“Jiangsu Alphamab Biopharmaceuticals”
全部
1,123
临床试验
97
药物
387
机构
164
资讯
475
去年
Advancements in HER2-Positive Gastric Cancer Treatment Landscape
上个月
Pathos AI Licenses Experimental Triple-Negative Breast Cancer Drug from China's Alphamab in $125 Million Deal
去年
Hemophilia A and B Pipeline Advances with Novel Therapies in Clinical Trials
去年
Alphamab Oncology's JSKN033 Shows Promise in HER2-Expressing Solid Tumors
去年
Recbio Initiates Phase III Trial of REC610 Shingles Vaccine in China
去年
Hansoh Pharma's HS-20093 ADC Granted Breakthrough Therapy Designation for SCLC in China
去年
Alphamab Oncology Retracts Announcement on JSKN033 Clinical Trial Inclusion
10个月前
Alphamab Oncology's JSKN003 Receives FDA Fast Track Designation for Platinum-Resistant Ovarian Cancer
去年
Alphamab Oncology's HER2-Targeting ADC JSKN003 Receives FDA Orphan Drug Designation for Gastric Cancer
去年
Chinese Drugmaker Jiangsu Hengrui Becomes World's Top Clinical Trial Sponsor as China Transforms Global R&D Landscape
第 1 页，共 48 页
上一页
下一页
